Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.03437514 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.03437514 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.02602851 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01483587 |
5 | NIK/NF-kappaB signaling (GO:0038061) | 4.80551475 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.71197260 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.71197260 |
8 | modulation by symbiont of host immune response (GO:0052553) | 4.71197260 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.71197260 |
10 | modulation by symbiont of host defense response (GO:0052031) | 4.71197260 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.71197260 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.64958931 |
13 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.34798488 |
14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.18536475 |
15 | response to muramyl dipeptide (GO:0032495) | 4.18010910 |
16 | response to peptidoglycan (GO:0032494) | 4.12226567 |
17 | immunoglobulin mediated immune response (GO:0016064) | 3.94521319 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 3.82091206 |
19 | neutrophil activation involved in immune response (GO:0002283) | 3.79601604 |
20 | macrophage activation involved in immune response (GO:0002281) | 3.67905116 |
21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67867287 |
22 | regulation of vitamin metabolic process (GO:0030656) | 3.63433321 |
23 | negative regulation of interleukin-12 production (GO:0032695) | 3.62088568 |
24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55824454 |
25 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.54319418 |
26 | leukocyte aggregation (GO:0070486) | 3.48816272 |
27 | positive regulation of interferon-alpha production (GO:0032727) | 3.47547019 |
28 | response to type I interferon (GO:0034340) | 3.47083320 |
29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.45292349 |
30 | type I interferon signaling pathway (GO:0060337) | 3.45002611 |
31 | cellular response to type I interferon (GO:0071357) | 3.45002611 |
32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.42033849 |
33 | positive regulation of heat generation (GO:0031652) | 3.41338083 |
34 | regulation of interferon-alpha production (GO:0032647) | 3.38194818 |
35 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.36461905 |
36 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.35337114 |
37 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.31346649 |
38 | myeloid dendritic cell differentiation (GO:0043011) | 3.30996566 |
39 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.26562292 |
40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.26512920 |
41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.25330362 |
42 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.25316022 |
43 | positive thymic T cell selection (GO:0045059) | 3.23969631 |
44 | detection of other organism (GO:0098543) | 3.23393135 |
45 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.16129775 |
46 | respiratory burst (GO:0045730) | 3.15874465 |
47 | detection of bacterium (GO:0016045) | 3.13858249 |
48 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.11421422 |
49 | response to host immune response (GO:0052572) | 3.11421422 |
50 | B cell mediated immunity (GO:0019724) | 3.11225195 |
51 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.06304984 |
52 | positive regulation of type 2 immune response (GO:0002830) | 3.05800659 |
53 | granulocyte activation (GO:0036230) | 3.05694643 |
54 | positive regulation of interferon-beta production (GO:0032728) | 3.05384155 |
55 | myeloid dendritic cell activation (GO:0001773) | 3.04294513 |
56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.02682179 |
57 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.01904493 |
58 | regulation of fever generation (GO:0031620) | 2.96780095 |
59 | regulation of response to interferon-gamma (GO:0060330) | 2.96517569 |
60 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95769939 |
61 | response to host (GO:0075136) | 2.95769939 |
62 | response to host defenses (GO:0052200) | 2.95769939 |
63 | cellular response to zinc ion (GO:0071294) | 2.94970202 |
64 | * leukocyte cell-cell adhesion (GO:0007159) | 2.94614606 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.94538700 |
66 | regulation of chemokine biosynthetic process (GO:0045073) | 2.93539388 |
67 | detection of molecule of bacterial origin (GO:0032490) | 2.93429511 |
68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92901360 |
69 | neutrophil activation (GO:0042119) | 2.92647652 |
70 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.92394202 |
71 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.92340687 |
72 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.90134515 |
73 | natural killer cell mediated immunity (GO:0002228) | 2.90134515 |
74 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.89430125 |
75 | regulation of antigen processing and presentation (GO:0002577) | 2.89049366 |
76 | positive regulation of B cell differentiation (GO:0045579) | 2.85535299 |
77 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.85100568 |
78 | detection of external biotic stimulus (GO:0098581) | 2.84813356 |
79 | regulation of podosome assembly (GO:0071801) | 2.84793604 |
80 | low-density lipoprotein particle clearance (GO:0034383) | 2.84336565 |
81 | regulation of interleukin-12 production (GO:0032655) | 2.84249459 |
82 | negative regulation of cell killing (GO:0031342) | 2.84047211 |
83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84047211 |
84 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.83744513 |
85 | positive regulation of interleukin-12 production (GO:0032735) | 2.83220426 |
86 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.81813765 |
87 | T cell migration (GO:0072678) | 2.81776852 |
88 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.81069577 |
89 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.80373002 |
90 | tolerance induction (GO:0002507) | 2.79999178 |
91 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79949956 |
92 | positive regulation of humoral immune response (GO:0002922) | 2.79150645 |
93 | defense response to protozoan (GO:0042832) | 2.79142321 |
94 | germinal center formation (GO:0002467) | 2.78371204 |
95 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.77173820 |
96 | activation of MAPKKK activity (GO:0000185) | 2.76494356 |
97 | myeloid cell activation involved in immune response (GO:0002275) | 2.75487807 |
98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75323399 |
99 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.74829331 |
100 | regulation of chronic inflammatory response (GO:0002676) | 2.74516124 |
101 | cellular response to interferon-gamma (GO:0071346) | 2.73937495 |
102 | negative thymic T cell selection (GO:0045060) | 2.73711279 |
103 | regulation of cholesterol storage (GO:0010885) | 2.73400939 |
104 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.73248177 |
105 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.73231703 |
106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.72343725 |
107 | cellular response to lipopolysaccharide (GO:0071222) | 2.71549987 |
108 | regulation of T cell tolerance induction (GO:0002664) | 2.71303843 |
109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.70463921 |
110 | cellular response to virus (GO:0098586) | 2.69934345 |
111 | regulation of mononuclear cell migration (GO:0071675) | 2.68690115 |
112 | regulation of type 2 immune response (GO:0002828) | 2.67749175 |
113 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.67347880 |
114 | cellular response to molecule of bacterial origin (GO:0071219) | 2.66893160 |
115 | dendritic cell differentiation (GO:0097028) | 2.66779348 |
116 | T-helper 1 type immune response (GO:0042088) | 2.65534338 |
117 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.64280944 |
118 | regulation of integrin activation (GO:0033623) | 2.64055321 |
119 | response to protozoan (GO:0001562) | 2.63052467 |
120 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62749187 |
121 | negative T cell selection (GO:0043383) | 2.62593057 |
122 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.62529584 |
123 | cytokine secretion (GO:0050663) | 2.62327012 |
124 | positive regulation of interleukin-2 production (GO:0032743) | 2.62215769 |
125 | cellular response to interferon-beta (GO:0035458) | 2.61013891 |
126 | response to interferon-gamma (GO:0034341) | 2.60518041 |
127 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.59960216 |
128 | protein localization to endosome (GO:0036010) | 2.59779473 |
129 | negative regulation of lipid storage (GO:0010888) | 2.58592875 |
130 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58136347 |
131 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.57804786 |
132 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.57481327 |
133 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.57133583 |
134 | mature B cell differentiation involved in immune response (GO:0002313) | 2.56344433 |
135 | macrophage activation (GO:0042116) | 2.56299189 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89996107 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.33012407 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.91737499 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.60479612 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51533806 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.22743973 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.22020314 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04208342 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.01772107 |
10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92396549 |
11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88004122 |
12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76853148 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.75724084 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.75415278 |
15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.70933342 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58958850 |
17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.39728266 |
18 | MYC_22102868_ChIP-Seq_BL_Human | 2.35330782 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30951827 |
20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29701867 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28645951 |
22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.27179859 |
23 | * MAF_26560356_Chip-Seq_TH1_Human | 2.09558595 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09480497 |
25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08679601 |
26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03842585 |
27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.89252394 |
28 | MYB_26560356_Chip-Seq_TH2_Human | 1.87988131 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81405729 |
30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80709447 |
31 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78375373 |
32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77371279 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73601971 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.72763722 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72482157 |
36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71488151 |
37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68221938 |
38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.67004143 |
39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65689819 |
40 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64793383 |
41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57591598 |
42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57561826 |
43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56825291 |
44 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51585027 |
45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50066934 |
46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46936244 |
47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43995857 |
48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41743066 |
49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41470919 |
50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32668816 |
51 | MAF_26560356_Chip-Seq_TH2_Human | 1.32298306 |
52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32221811 |
53 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31871684 |
54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.29773346 |
55 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29512048 |
56 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27236167 |
57 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23964756 |
58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20465032 |
59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19314772 |
60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16130239 |
61 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16108812 |
62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15813263 |
63 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15426671 |
64 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.15386019 |
65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14402195 |
66 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14116624 |
67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11551297 |
68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10238340 |
69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09927431 |
70 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08990354 |
71 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07862570 |
72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07309624 |
73 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07199164 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06296273 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05791404 |
76 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.04563785 |
77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04353394 |
78 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04101845 |
79 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03884087 |
80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02918734 |
81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02185111 |
82 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01178990 |
83 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01072919 |
84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00957150 |
85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99832589 |
86 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99210750 |
87 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98934431 |
88 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98858254 |
89 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98319246 |
90 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98021260 |
91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97913096 |
92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97752374 |
93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97333216 |
94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96969464 |
95 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96829694 |
96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96349424 |
97 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96235725 |
98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95423780 |
99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95341281 |
100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95046367 |
101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93632090 |
102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93072512 |
103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92556670 |
104 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.90759736 |
105 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.89785553 |
106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89432098 |
107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88545949 |
108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.87881548 |
109 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85884191 |
110 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.85730557 |
111 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85359170 |
112 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.84244407 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84180825 |
114 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83451295 |
115 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82594143 |
116 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82594143 |
117 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81932626 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.62809193 |
2 | MP0003303_peritoneal_inflammation | 3.33579672 |
3 | MP0000685_abnormal_immune_system | 3.30376025 |
4 | MP0003436_decreased_susceptibility_to | 3.14830802 |
5 | MP0009785_altered_susceptibility_to | 3.12350972 |
6 | MP0004510_myositis | 2.86222781 |
7 | MP0005387_immune_system_phenotype | 2.76340363 |
8 | MP0001790_abnormal_immune_system | 2.76340363 |
9 | MP0005000_abnormal_immune_tolerance | 2.70575667 |
10 | MP0006082_CNS_inflammation | 2.69704075 |
11 | MP0002254_reproductive_system_inflammat | 2.68019542 |
12 | MP0005025_abnormal_response_to | 2.50251500 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.49655165 |
14 | MP0005451_abnormal_body_composition | 2.49084989 |
15 | MP0001800_abnormal_humoral_immune | 2.48387270 |
16 | MP0002419_abnormal_innate_immunity | 2.45464897 |
17 | MP0005671_abnormal_response_to | 2.45374920 |
18 | MP0009278_abnormal_bone_marrow | 2.42720950 |
19 | MP0002452_abnormal_antigen_presenting | 2.39172778 |
20 | MP0004947_skin_inflammation | 2.32281609 |
21 | MP0002723_abnormal_immune_serum | 2.28944431 |
22 | MP0003724_increased_susceptibility_to | 2.22634929 |
23 | MP0001819_abnormal_immune_cell | 2.11020237 |
24 | MP0002420_abnormal_adaptive_immunity | 2.09088327 |
25 | MP0010155_abnormal_intestine_physiology | 1.99608481 |
26 | MP0002405_respiratory_system_inflammati | 1.96331382 |
27 | MP0003300_gastrointestinal_ulcer | 1.90888461 |
28 | MP0002139_abnormal_hepatobiliary_system | 1.87956660 |
29 | MP0003763_abnormal_thymus_physiology | 1.84744746 |
30 | MP0005058_abnormal_lysosome_morphology | 1.83583880 |
31 | MP0009333_abnormal_splenocyte_physiolog | 1.81358366 |
32 | MP0010352_gastrointestinal_tract_polyps | 1.78676219 |
33 | MP0005464_abnormal_platelet_physiology | 1.76770946 |
34 | MP0005397_hematopoietic_system_phenotyp | 1.75786350 |
35 | MP0001545_abnormal_hematopoietic_system | 1.75786350 |
36 | MP0003448_altered_tumor_morphology | 1.73965216 |
37 | MP0001845_abnormal_inflammatory_respons | 1.73557907 |
38 | MP0002398_abnormal_bone_marrow | 1.70921006 |
39 | MP0001873_stomach_inflammation | 1.70224816 |
40 | MP0005076_abnormal_cell_differentiation | 1.69875659 |
41 | MP0001533_abnormal_skeleton_physiology | 1.68729938 |
42 | MP0001853_heart_inflammation | 1.67559326 |
43 | MP0000716_abnormal_immune_system | 1.65747463 |
44 | MP0002006_tumorigenesis | 1.61576339 |
45 | MP0000343_altered_response_to | 1.57599961 |
46 | MP0002166_altered_tumor_susceptibility | 1.54987763 |
47 | MP0005310_abnormal_salivary_gland | 1.52702975 |
48 | MP0009840_abnormal_foam_cell | 1.51256174 |
49 | MP0003566_abnormal_cell_adhesion | 1.45505318 |
50 | MP0003172_abnormal_lysosome_physiology | 1.41298176 |
51 | MP0000689_abnormal_spleen_morphology | 1.40268610 |
52 | MP0002722_abnormal_immune_system | 1.39454770 |
53 | MP0000858_altered_metastatic_potential | 1.38126017 |
54 | MP0010307_abnormal_tumor_latency | 1.37835228 |
55 | MP0003453_abnormal_keratinocyte_physiol | 1.36859150 |
56 | * MP0002429_abnormal_blood_cell | 1.36215254 |
57 | MP0008004_abnormal_stomach_pH | 1.34517898 |
58 | MP0008469_abnormal_protein_level | 1.33403143 |
59 | MP0003828_pulmonary_edema | 1.30854115 |
60 | MP0003705_abnormal_hypodermis_morpholog | 1.27382497 |
61 | MP0008260_abnormal_autophagy | 1.27204177 |
62 | MP0009764_decreased_sensitivity_to | 1.25226463 |
63 | MP0005023_abnormal_wound_healing | 1.21576006 |
64 | MP0003656_abnormal_erythrocyte_physiolo | 1.19532842 |
65 | MP0003866_abnormal_defecation | 1.16224643 |
66 | MP0002998_abnormal_bone_remodeling | 1.11727986 |
67 | MP0003075_altered_response_to | 1.11537609 |
68 | MP0003806_abnormal_nucleotide_metabolis | 1.11321482 |
69 | MP0000703_abnormal_thymus_morphology | 1.08479170 |
70 | MP0004808_abnormal_hematopoietic_stem | 1.07185390 |
71 | MP0002933_joint_inflammation | 1.05813434 |
72 | MP0003191_abnormal_cellular_cholesterol | 1.05379216 |
73 | MP0005167_abnormal_blood-brain_barrier | 1.03748230 |
74 | MP0000490_abnormal_crypts_of | 1.02832316 |
75 | MP0002138_abnormal_hepatobiliary_system | 1.02608633 |
76 | MP0001348_abnormal_lacrimal_gland | 0.99464511 |
77 | MP0003091_abnormal_cell_migration | 0.98598235 |
78 | MP0001851_eye_inflammation | 0.97827828 |
79 | MP0000604_amyloidosis | 0.97404488 |
80 | MP0003690_abnormal_glial_cell | 0.96657103 |
81 | MP0002396_abnormal_hematopoietic_system | 0.93644036 |
82 | MP0006054_spinal_hemorrhage | 0.91818717 |
83 | MP0002877_abnormal_melanocyte_morpholog | 0.88287630 |
84 | MP0005666_abnormal_adipose_tissue | 0.85467308 |
85 | MP0002277_abnormal_respiratory_mucosa | 0.84948163 |
86 | MP0004858_abnormal_nervous_system | 0.84669949 |
87 | MP0005166_decreased_susceptibility_to | 0.83710826 |
88 | MP0003045_fibrosis | 0.83572776 |
89 | MP0003183_abnormal_peptide_metabolism | 0.82175036 |
90 | MP0008874_decreased_physiological_sensi | 0.79415516 |
91 | MP0005165_increased_susceptibility_to | 0.78615644 |
92 | MP0004883_abnormal_blood_vessel | 0.78514785 |
93 | MP0005390_skeleton_phenotype | 0.78504108 |
94 | MP0009763_increased_sensitivity_to | 0.78046049 |
95 | MP0000733_abnormal_muscle_development | 0.77047845 |
96 | MP0000249_abnormal_blood_vessel | 0.74356476 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.73919078 |
98 | MP0000465_gastrointestinal_hemorrhage | 0.70558989 |
99 | MP0002019_abnormal_tumor_incidence | 0.69607088 |
100 | MP0003329_amyloid_beta_deposits | 0.69134714 |
101 | MP0000750_abnormal_muscle_regeneration | 0.68552889 |
102 | MP0004185_abnormal_adipocyte_glucose | 0.68425239 |
103 | MP0000569_abnormal_digit_pigmentation | 0.68134374 |
104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68004840 |
105 | MP0001542_abnormal_bone_strength | 0.67721537 |
106 | MP0000371_diluted_coat_color | 0.67459803 |
107 | MP0003646_muscle_fatigue | 0.66675932 |
108 | MP0003279_aneurysm | 0.64342899 |
109 | MP0001849_ear_inflammation | 0.62917721 |
110 | MP0002332_abnormal_exercise_endurance | 0.62612486 |
111 | MP0005164_abnormal_response_to | 0.62378577 |
112 | MP0001663_abnormal_digestive_system | 0.61907597 |
113 | MP0002136_abnormal_kidney_physiology | 0.61582307 |
114 | MP0003795_abnormal_bone_structure | 0.60857129 |
115 | MP0004782_abnormal_surfactant_physiolog | 0.58963009 |
116 | MP0005621_abnormal_cell_physiology | 0.56072010 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.19262504 |
2 | Recurrent abscess formation (HP:0002722) | 5.68024809 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.22465188 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.01548075 |
5 | Stomatitis (HP:0010280) | 4.65060805 |
6 | Myositis (HP:0100614) | 4.46581304 |
7 | Recurrent fungal infections (HP:0002841) | 4.36466689 |
8 | Mediastinal lymphadenopathy (HP:0100721) | 4.28643034 |
9 | Abnormality of macrophages (HP:0004311) | 4.22916624 |
10 | Orchitis (HP:0100796) | 4.12653246 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99721690 |
12 | Autoimmune thrombocytopenia (HP:0001973) | 3.98655868 |
13 | Pustule (HP:0200039) | 3.89666095 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.83313625 |
15 | Optic neuritis (HP:0100653) | 3.83313625 |
16 | Recurrent skin infections (HP:0001581) | 3.60258262 |
17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.58334317 |
18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.58334317 |
19 | Recurrent viral infections (HP:0004429) | 3.54024887 |
20 | Gingivitis (HP:0000230) | 3.48733648 |
21 | Interstitial pulmonary disease (HP:0006530) | 3.25353317 |
22 | Vasculitis (HP:0002633) | 3.24248566 |
23 | Chronic otitis media (HP:0000389) | 3.20376104 |
24 | Increased cerebral lipofuscin (HP:0011813) | 3.18590659 |
25 | Loss of speech (HP:0002371) | 3.11618671 |
26 | Nasal polyposis (HP:0100582) | 3.09201569 |
27 | Obstructive lung disease (HP:0006536) | 3.02226031 |
28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.02226031 |
29 | Abnormality of the nasal mucosa (HP:0000433) | 2.89865365 |
30 | Cellulitis (HP:0100658) | 2.87969064 |
31 | Keratoconjunctivitis (HP:0001096) | 2.84699763 |
32 | Pulmonary infiltrates (HP:0002113) | 2.82450688 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71221192 |
34 | Arterial thrombosis (HP:0004420) | 2.68783704 |
35 | Increased IgE level (HP:0003212) | 2.65673767 |
36 | Leukocytosis (HP:0001974) | 2.64516606 |
37 | Urticaria (HP:0001025) | 2.63950369 |
38 | Vacuolated lymphocytes (HP:0001922) | 2.61367934 |
39 | Periodontitis (HP:0000704) | 2.60445359 |
40 | Amyloidosis (HP:0011034) | 2.59389872 |
41 | Colitis (HP:0002583) | 2.59248076 |
42 | Disinhibition (HP:0000734) | 2.58100823 |
43 | Increased IgM level (HP:0003496) | 2.53486513 |
44 | Recurrent bronchitis (HP:0002837) | 2.50594032 |
45 | Hematochezia (HP:0002573) | 2.49838042 |
46 | Inflammation of the large intestine (HP:0002037) | 2.47727920 |
47 | Meningitis (HP:0001287) | 2.47218124 |
48 | Emphysema (HP:0002097) | 2.44104621 |
49 | Gastrointestinal inflammation (HP:0004386) | 2.43120654 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42942492 |
51 | Axonal loss (HP:0003447) | 2.42476714 |
52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40031766 |
53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40031766 |
54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40031766 |
55 | Nuclear cataract (HP:0100018) | 2.39648150 |
56 | Hemoptysis (HP:0002105) | 2.38608111 |
57 | Tetraparesis (HP:0002273) | 2.38155000 |
58 | Keratoconjunctivitis sicca (HP:0001097) | 2.37992742 |
59 | Glomerulonephritis (HP:0000099) | 2.37974917 |
60 | Gangrene (HP:0100758) | 2.36527566 |
61 | Abnormality of T cell number (HP:0011839) | 2.35848342 |
62 | Neurofibrillary tangles (HP:0002185) | 2.35399419 |
63 | Malnutrition (HP:0004395) | 2.33133573 |
64 | Hypergammaglobulinemia (HP:0010702) | 2.30520385 |
65 | Myocardial infarction (HP:0001658) | 2.26823638 |
66 | Premature loss of primary teeth (HP:0006323) | 2.26528087 |
67 | Purpura (HP:0000979) | 2.26493974 |
68 | Basal ganglia calcification (HP:0002135) | 2.25388730 |
69 | Abnormality of T cells (HP:0002843) | 2.24486870 |
70 | T lymphocytopenia (HP:0005403) | 2.24208809 |
71 | Encephalitis (HP:0002383) | 2.23879386 |
72 | Gastrointestinal stroma tumor (HP:0100723) | 2.23570498 |
73 | Osteomyelitis (HP:0002754) | 2.22444029 |
74 | Frequent falls (HP:0002359) | 2.17171056 |
75 | Vertebral compression fractures (HP:0002953) | 2.15998599 |
76 | Thick nail (HP:0001805) | 2.15881045 |
77 | Thin bony cortex (HP:0002753) | 2.13865769 |
78 | Gastrointestinal infarctions (HP:0005244) | 2.13349639 |
79 | Abnormality of T cell physiology (HP:0011840) | 2.13270855 |
80 | Thrombocytosis (HP:0001894) | 2.09472998 |
81 | Asymmetric septal hypertrophy (HP:0001670) | 2.07954786 |
82 | Eosinophilia (HP:0001880) | 2.06624546 |
83 | Cerebral inclusion bodies (HP:0100314) | 2.06223696 |
84 | Skin ulcer (HP:0200042) | 2.04523821 |
85 | Dysostosis multiplex (HP:0000943) | 2.03218061 |
86 | IgM deficiency (HP:0002850) | 2.02651868 |
87 | Cheilitis (HP:0100825) | 2.02578978 |
88 | Chest pain (HP:0100749) | 2.01843775 |
89 | IgA deficiency (HP:0002720) | 2.01583328 |
90 | Restrictive lung disease (HP:0002091) | 2.01329736 |
91 | Spontaneous hematomas (HP:0007420) | 2.00483014 |
92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.99605048 |
93 | Abnormality of iron homeostasis (HP:0011031) | 1.98161668 |
94 | Hypertensive crisis (HP:0100735) | 1.94156680 |
95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.93944790 |
96 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93349856 |
97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93349856 |
98 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93349856 |
99 | Hepatosplenomegaly (HP:0001433) | 1.93256171 |
100 | Abnormality of complement system (HP:0005339) | 1.92960589 |
101 | Gingival bleeding (HP:0000225) | 1.92785502 |
102 | Prostate neoplasm (HP:0100787) | 1.92622056 |
103 | Abnormality of the pleura (HP:0002103) | 1.91500682 |
104 | Pulmonary embolism (HP:0002204) | 1.91216333 |
105 | Lymphopenia (HP:0001888) | 1.91077545 |
106 | Glomerulopathy (HP:0100820) | 1.90665035 |
107 | Abnormality of the fingertips (HP:0001211) | 1.90480334 |
108 | Petechiae (HP:0000967) | 1.90271812 |
109 | Esophageal varix (HP:0002040) | 1.87844479 |
110 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87642819 |
111 | Mucopolysacchariduria (HP:0008155) | 1.87642819 |
112 | Anorexia (HP:0002039) | 1.87571916 |
113 | Panhypogammaglobulinemia (HP:0003139) | 1.86482061 |
114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85516374 |
115 | Osteolytic defects of the hand bones (HP:0009699) | 1.85516374 |
116 | Mutism (HP:0002300) | 1.85327998 |
117 | Complement deficiency (HP:0004431) | 1.85011012 |
118 | Neuronal loss in central nervous system (HP:0002529) | 1.85001628 |
119 | Persistence of primary teeth (HP:0006335) | 1.84367303 |
120 | Polyneuropathy (HP:0001271) | 1.83393156 |
121 | Increased serum ferritin (HP:0003281) | 1.82445275 |
122 | Polygenic inheritance (HP:0010982) | 1.82380425 |
123 | Joint swelling (HP:0001386) | 1.81855223 |
124 | Abnormality of the pericardium (HP:0001697) | 1.81776650 |
125 | Arthralgia (HP:0002829) | 1.81708268 |
126 | Systemic lupus erythematosus (HP:0002725) | 1.81591457 |
127 | Autoimmune hemolytic anemia (HP:0001890) | 1.80031476 |
128 | Abnormality of eosinophils (HP:0001879) | 1.79362951 |
129 | Recurrent lower respiratory tract infections (HP:0002783) | 1.79077954 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.00011990 |
2 | MAP4K1 | 3.57644433 |
3 | TBK1 | 3.42330072 |
4 | PRPF4B | 3.12350844 |
5 | TYK2 | 2.85833889 |
6 | JAK3 | 2.79889029 |
7 | IRAK3 | 2.72572937 |
8 | IKBKE | 2.64953887 |
9 | TAOK2 | 2.38736129 |
10 | ERN1 | 2.35169657 |
11 | TXK | 2.30608173 |
12 | IKBKB | 2.28210895 |
13 | RIPK4 | 2.21397274 |
14 | MAP3K10 | 1.96990558 |
15 | TRIB3 | 1.93571936 |
16 | STK10 | 1.92424626 |
17 | DDR2 | 1.91700821 |
18 | JAK1 | 1.88659607 |
19 | IRAK4 | 1.86581216 |
20 | FGFR4 | 1.82865009 |
21 | ZAP70 | 1.82494667 |
22 | EPHB1 | 1.81729321 |
23 | BLK | 1.81043351 |
24 | CHUK | 1.80665245 |
25 | NME2 | 1.68671649 |
26 | KIT | 1.66889086 |
27 | GRK7 | 1.60618855 |
28 | MAP3K13 | 1.60446519 |
29 | TTN | 1.57330041 |
30 | CDK12 | 1.56038997 |
31 | CDC42BPA | 1.54366639 |
32 | MOS | 1.52576232 |
33 | CSK | 1.49676895 |
34 | PKN2 | 1.47535186 |
35 | RPS6KA4 | 1.43071064 |
36 | PIM2 | 1.32585866 |
37 | PIM1 | 1.29085176 |
38 | PTK6 | 1.24486114 |
39 | LRRK2 | 1.21580743 |
40 | BTK | 1.20221498 |
41 | HCK | 1.19222382 |
42 | MAP2K3 | 1.17993132 |
43 | TGFBR2 | 1.17396568 |
44 | LCK | 1.16351983 |
45 | BMX | 1.14720508 |
46 | SIK3 | 1.14400935 |
47 | SYK | 1.14258077 |
48 | JAK2 | 1.11731649 |
49 | SMG1 | 1.10338637 |
50 | RIPK1 | 1.09705338 |
51 | MARK3 | 1.09607122 |
52 | BMPR2 | 1.09011785 |
53 | ITK | 1.06832823 |
54 | FGFR3 | 1.06371390 |
55 | MAP3K11 | 1.03793926 |
56 | GRK6 | 1.02296400 |
57 | MST4 | 1.01933542 |
58 | EPHA3 | 1.01276242 |
59 | ICK | 0.98559504 |
60 | TAOK3 | 0.97278662 |
61 | EEF2K | 0.96674594 |
62 | CSF1R | 0.96122819 |
63 | IRAK2 | 0.93708692 |
64 | ARAF | 0.92432361 |
65 | MAP3K3 | 0.85818062 |
66 | MATK | 0.82738805 |
67 | FLT3 | 0.82563560 |
68 | PDGFRA | 0.77739634 |
69 | TEC | 0.76596016 |
70 | TESK2 | 0.75611618 |
71 | KDR | 0.75177955 |
72 | MST1R | 0.74061900 |
73 | LYN | 0.71735944 |
74 | ALK | 0.69390791 |
75 | PRKG2 | 0.68720020 |
76 | NLK | 0.68531570 |
77 | HIPK2 | 0.67824630 |
78 | TAOK1 | 0.66023612 |
79 | PDPK1 | 0.64715287 |
80 | PAK4 | 0.64351894 |
81 | SIK2 | 0.58462184 |
82 | PDK1 | 0.58201515 |
83 | FGR | 0.57441258 |
84 | TRPM7 | 0.56449499 |
85 | EGFR | 0.55647554 |
86 | MARK2 | 0.54934998 |
87 | MAP3K8 | 0.54603204 |
88 | MAP3K1 | 0.54036698 |
89 | NEK2 | 0.53788884 |
90 | TESK1 | 0.53381433 |
91 | CDK4 | 0.52262186 |
92 | MAPK7 | 0.49993225 |
93 | ABL2 | 0.49850339 |
94 | MAP3K7 | 0.49733264 |
95 | TNK2 | 0.49443309 |
96 | STK4 | 0.49234163 |
97 | MAP3K5 | 0.49126906 |
98 | TYRO3 | 0.48813758 |
99 | ABL1 | 0.48118529 |
100 | MAPKAPK2 | 0.47852234 |
101 | FES | 0.47814585 |
102 | MAPK4 | 0.47391069 |
103 | CDK6 | 0.46661824 |
104 | PRKD2 | 0.46322547 |
105 | DMPK | 0.45027726 |
106 | RPS6KA6 | 0.44021864 |
107 | PDGFRB | 0.43273567 |
108 | PRKCD | 0.42799874 |
109 | MAPK11 | 0.42685977 |
110 | EPHA2 | 0.41584558 |
111 | RPS6KA1 | 0.39028177 |
112 | NEK9 | 0.37825005 |
113 | DAPK3 | 0.37449381 |
114 | CLK1 | 0.37438007 |
115 | MAP2K6 | 0.37293257 |
116 | MAPK12 | 0.36540479 |
117 | RPS6KA2 | 0.36072045 |
118 | MAP2K2 | 0.34516667 |
119 | LATS2 | 0.34137357 |
120 | TGFBR1 | 0.34085255 |
121 | RPS6KB2 | 0.33979760 |
122 | SIK1 | 0.32996270 |
123 | PTK2 | 0.32950074 |
124 | STK24 | 0.31281906 |
125 | MTOR | 0.30848839 |
126 | STK3 | 0.29182966 |
127 | RPS6KC1 | 0.28123035 |
128 | RPS6KL1 | 0.28123035 |
129 | KSR2 | 0.28115746 |
130 | DYRK1B | 0.27972601 |
131 | IRAK1 | 0.26781162 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.35176792 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95788027 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.60186571 |
4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.38949922 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.38620140 |
6 | Legionellosis_Homo sapiens_hsa05134 | 2.32460284 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28478513 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24164264 |
9 | Measles_Homo sapiens_hsa05162 | 2.21702408 |
10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.13218058 |
11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.07874168 |
12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07237818 |
13 | Allograft rejection_Homo sapiens_hsa05330 | 2.04825449 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94145074 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92305449 |
16 | Malaria_Homo sapiens_hsa05144 | 1.91854450 |
17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.88199978 |
18 | Pertussis_Homo sapiens_hsa05133 | 1.85516342 |
19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85432617 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.83918697 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83392812 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.80009932 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70375043 |
24 | Asthma_Homo sapiens_hsa05310 | 1.66869001 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64957109 |
26 | Apoptosis_Homo sapiens_hsa04210 | 1.63080280 |
27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54150167 |
28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51867381 |
29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51642274 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48748058 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.48093879 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.47407471 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.44646485 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.40243588 |
35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.38328894 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35018570 |
37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32865670 |
38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28794540 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.27573200 |
40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27480654 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26412514 |
42 | Lysosome_Homo sapiens_hsa04142 | 1.20325944 |
43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18864413 |
44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18234586 |
45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17859512 |
46 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14495340 |
47 | Prion diseases_Homo sapiens_hsa05020 | 1.14304576 |
48 | Hepatitis C_Homo sapiens_hsa05160 | 1.12993661 |
49 | Bladder cancer_Homo sapiens_hsa05219 | 1.09189837 |
50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08182217 |
51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04549271 |
52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.04216470 |
53 | Amoebiasis_Homo sapiens_hsa05146 | 1.00131071 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98723036 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97122374 |
56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96971863 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96518106 |
58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94565275 |
59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85822257 |
60 | Phagosome_Homo sapiens_hsa04145 | 0.85320875 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84958854 |
62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84257440 |
63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79613090 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79386856 |
65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75816514 |
66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75645162 |
67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70634724 |
68 | Insulin resistance_Homo sapiens_hsa04931 | 0.70374094 |
69 | Platelet activation_Homo sapiens_hsa04611 | 0.67298299 |
70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66060700 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62970894 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61059427 |
73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60854691 |
74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59899994 |
75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58738531 |
76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58336756 |
77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58205505 |
78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.56803710 |
79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56095754 |
80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52596208 |
81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51161500 |
82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50227812 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45596520 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42852619 |
85 | Adherens junction_Homo sapiens_hsa04520 | 0.41643016 |
86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40507267 |
87 | Focal adhesion_Homo sapiens_hsa04510 | 0.40464035 |
88 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39521913 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.38145976 |
90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37772045 |
91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37310054 |
92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35483485 |
93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34743869 |
94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34285773 |
95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34037665 |
96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33069606 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31560278 |
98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31117962 |
99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.31058644 |
100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30675632 |
101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29810841 |
102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29426003 |
103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29414299 |
104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28297791 |
105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27688391 |
106 | Mineral absorption_Homo sapiens_hsa04978 | 0.27572828 |
107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27471234 |
108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27326313 |
109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27092935 |
110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26728118 |
111 | Prostate cancer_Homo sapiens_hsa05215 | 0.26119550 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24913746 |
113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24882728 |
114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24342480 |